As AI accelerates drug discovery, the industry’s next challenge is building a connected, standards-based data infrastructure capable of supporting it through clinical development.
Dave Sunderhaft
Advertisement
Dave Sunderhaft is the Chief Operating Officer at nPhase, Inc., the clinical trial technology company behind REDCap Cloud and nPhase.ai. With over two decades in clinical research including leading Parexel's eClinical Solutions group before joining nPhase, Dave focuses on bringing emerging technology into production across the clinical data lifecycle, from data capture through submission.
Articles by Dave Sunderhaft
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
The Next Biopharma Revolution: Quantum Computing
2
Roundup: Astellas Licenses IL-12 Fusion Protein From Audax in Deal Worth Up to $1.34 Billion, EVERSANA Acquires Health Economics Firm Estima Scientific
3
How Medications like XOCOVA Prevent Illness After Exposure to COVID-19
4
Caution and Pharma’s AI Adoption: Understanding the Reasons Behind Uneven Uptake
5